Skip to main content
. Author manuscript; available in PMC: 2023 Oct 4.
Published in final edited form as: J Am Coll Cardiol. 2022 Oct 4;80(14):1287–1298. doi: 10.1016/j.jacc.2022.07.027

FIGURE 1. Study Flow Chart Indicating the Selection of the Final Data Set.

FIGURE 1

The ASPREE (ASPirin in Reducing Events in the Elderly) trial enrolled 19,114 individuals ≥70 years (≥65 years for U.S. minorities) with no prior history of cardiovascular disease events. DNA samples were provided by 14,052 ASPREE Biobank participants at enrollment. Genotyped samples were excluded for failed quality control (n = 142) and ancestry stratification (n = 959). The final data set (n = 12,815) included only genotyped participants with European descent ≥70 years of age.